Eric Hoffman

Q: What Schools Are Affiliated With Eric Hoffman

Eric Hoffman is affiliated with the following schools: University of Dublin, University of Pittsburgh, University of Massachusetts, Harvard University, George Washington University, Binghamton University, Central Connecticut State University, Charing Cross and Westminster Medical School, Dalhousie University

Eric Hoffman's AcademicInfluence.com Rankings

Eric Hoffman

Chemistry

#1435

World Rank

#2146

Historical Rank

chemistry Degrees

Download Badge

Chemistry

Why Is Eric Hoffman Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Eric Hoffman's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Dystrophin: The protein product of the duchenne muscular dystrophy locus (1987) (4384)
Complete cloning of the duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals (1987) (2306)
Conversion of mdx myofibres from dystrophin-negative to -positive by injection of normal myoblasts (1989) (892)
Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. (1988) (842)
Glucose restriction inhibits skeletal myoblast differentiation by activating SIRT1 through AMPK-mediated regulation of Nampt. (2008) (747)
Sir2 regulates skeletal muscle differentiation as a potential sensor of the redox state. (2003) (609)
Duchenne muscular dystrophy: Deficiency of dystrophin at the muscle cell surface (1988) (604)
Expression Profiling in the Muscular Dystrophies Identification of Novel Aspects of Molecular Pathophysiology (2000) (501)
β–sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex (1995) (454)
Immunoelectron microscopic localization of dystrophin in myofibres (1988) (439)
The homologue of the Duchenne locus is defective in X-linked muscular dystrophy of dogs (1988) (430)
Exploring the molecular basis for variability among patients with Becker muscular dystrophy: dystrophin gene and protein studies. (1991) (420)
Molecular cloning, structure, and chromosomal localization of the human inducible nitric oxide synthase gene. (1994) (402)
Variability in muscle size and strength gain after unilateral resistance training. (2005) (401)
Efficacy of systemic morpholino exon‐skipping in duchenne dystrophy dogs (2009) (378)
Elevated stearoyl-CoA desaturase-1 expression in skeletal muscle contributes to abnormal fatty acid partitioning in obese humans. (2005) (366)
Dystrophin abnormalities in Duchenne/Becker muscular dystrophy (1989) (325)
ACTN3 genotype is associated with increases in muscle strength in response to resistance training in women. (2005) (314)
Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. (2005) (311)
A Met-to-Val mutation in the skeletal muscle Na+ channel α-subunit in hyperkalaemic periodic paralysis (1991) (309)
Nuclear envelope dystrophies show a transcriptional fingerprint suggesting disruption of Rb-MyoD pathways in muscle regeneration. (2006) (298)
Genomics, intellectual disability, and autism. (2012) (298)
Subcellular fractionation of dystrophin to the triads of skeletal muscle (1987) (296)
The RNA helicases p68/p72 and the noncoding RNA SRA are coregulators of MyoD and skeletal muscle differentiation. (2006) (295)
Somatic reversion/suppression of the mouse mdx phenotype in vivo (1990) (293)
Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene. (1990) (292)
Gene profiling in spinal cord injury shows role of cell cycle in neuronal death (2003) (268)
Early onset of inflammation and later involvement of TGFβ in Duchenne muscular dystrophy (2005) (261)
Improved diagnosis of Becker muscular dystrophy by dystrophin testing (1989) (261)
Osteopontin promotes fibrosis in dystrophic mouse muscle by modulating immune cell subsets and intramuscular TGF-beta. (2009) (259)
Gentamicin treatment of Duchenne and Becker muscular dystrophy due to nonsense mutations (2001) (257)
Conservation of the Duchenne muscular dystrophy gene in mice and humans. (1987) (246)
Normal myogenic cells from newborn mice restore normal histology to degenerating muscles of the mdx mouse (1990) (245)
MeCP2 mutations in children with and without the phenotype of Rett syndrome (2001) (240)
Long-term effects of glucocorticoids on function, quality of life, and survival in patients with Duchenne muscular dystrophy: a prospective cohort study (2017) (232)
Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. (2004) (231)
Mutations in the sarcoglycan genes in patients with myopathy. (1997) (226)
Mutations in the integrin α7 gene cause congenital myopathy (1998) (226)
Caveolin-3 in muscular dystrophy. (1998) (222)
Large-scale serum protein biomarker discovery in Duchenne muscular dystrophy (2015) (219)
Loss of emerin at the nuclear envelope disrupts the Rb1/E2F and MyoD pathways during muscle regeneration. (2006) (218)
Contemporary Cardiac Issues in Duchenne Muscular Dystrophy (2015) (217)
Periodic paralysis in Quarter Horses: a sodium channel mutation disseminated by selective breeding (1992) (214)
ACTN3 and MLCK genotype associations with exertional muscle damage. (2005) (212)
Gene Expression Profiling in Postmortem Rett Syndrome Brain: Differential Gene Expression and Patient Classification (2001) (207)
Microtubules Underlie Dysfunction in Duchenne Muscular Dystrophy (2012) (205)
Identification of a chromosome 6-encoded dystrophin-related protein. (1990) (204)
Cell and fiber type distribution of dystrophin (1988) (202)
Rett syndrome: confirmation of X-linked dominant inheritance, and localization of the gene to Xq28. (1998) (201)
An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss (2015) (199)
Mutations in GDP-mannose pyrophosphorylase B cause congenital and limb-girdle muscular dystrophies associated with hypoglycosylation of α-dystroglycan. (2013) (194)
Rosenberg's Molecular and Genetic Basis of Neurological and Psychiatric Disease (2014) (192)
A web-accessible complete transcriptome of normal human and DMD muscle (2002) (190)
Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. (1995) (185)
Sources of variability and effect of experimental approach on expression profiling data interpretation (2002) (182)
Immune-mediated pathology in Duchenne muscular dystrophy (2015) (181)
Feline muscular dystrophy with dystrophin deficiency. (1989) (180)
Gene Expression Profiling in DQA1*0501+ Children with Untreated Dermatomyositis: A Novel Model of Pathogenesis1 (2002) (178)
Selective loss of sarcolemmal nitric oxide synthase in Becker muscular dystrophy (1996) (173)
The cooperative international neuromuscular research group Duchenne natural history study: Glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measur (2013) (172)
Response of rat muscle to acute resistance exercise defined by transcriptional and translational profiling (2002) (168)
Rare missense and synonymous variants in UBE1 are associated with X-linked infantile spinal muscular atrophy. (2008) (162)
Mutations in the integrin alpha7 gene cause congenital myopathy. (1998) (161)
Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. (2010) (161)
Molecular responses of human muscle to eccentric exercise. (2003) (158)
Preclinical drug trials in the mdx mouse: Assessment of reliable and sensitive outcome measures (2009) (158)
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies (2012) (157)
Skewed X inactivation in a female MZ twin results in Duchenne muscular dystrophy. (1990) (157)
Medium Chain Acyl-CoA Dehydrogenase Deficiency in Pennsylvania: Neonatal Screening Shows High Incidence and Unexpected Mutation Frequencies (1995) (157)
Dystrophin diagnosis: comparison of dystrophin abnormalities by immunofluorescence and immunoblot analyses. (1989) (155)
The cooperative international neuromuscular research group duchenne natural history study—a longitudinal investigation in the era of glucocorticoid therapy: Design of protocol and the methods used (2013) (146)
Dystrophinopathy in isolated cases of myopathy in females (1992) (144)
VBP15, a novel anti-inflammatory and membrane-stabilizer, improves muscular dystrophy without side effects (2013) (142)
Dystrophin deficiency causes lethal muscle hypertrophy in cats (1992) (140)
An interactive power analysis tool for microarray hypothesis testing and generation (2006) (139)
Familial skewed X inactivation: a molecular trait associated with high spontaneous-abortion rate maps to Xq28. (1997) (139)
Mutations That Disrupt the Carboxyl-Terminus of γ-Sarcoglycan Cause Muscular Dystrophy (1996) (137)
Bodywide skipping of exons 45–55 in dystrophic mdx52 mice by systemic antisense delivery (2012) (137)
Dystrophin-deficient cardiomyopathy in mouse: Expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart (2008) (134)
Interactively optimizing signal-to-noise ratios in expression profiling: project-specific algorithm selection and detection p-value weighting in Affymetrix microarrays (2004) (133)
Overexcited or inactive: Ion channels in muscle disease (1995) (133)
Prednisone/prednisolone and deflazacort regimens in the CINRG Duchenne Natural History Study (2015) (131)
Changes in Ubiquitin Proteasome Pathway Gene Expression in Skeletal Muscle With Exercise and Statins (2005) (131)
Heart involvement in muscular dystrophies due to sarcoglycan gene mutations (1999) (130)
Constitutive activation of MAPK cascade in acute quadriplegic myopathy (2004) (130)
GRB14, GPD1, and GDF8 as potential network collaborators in weight loss-induced improvements in insulin action in human skeletal muscle. (2006) (129)
A novel ryanodine receptor gene mutation causing both cores and rods in congenital myopathy (2000) (129)
Secreted proteome profiling in human RPE cell cultures derived from donors with age related macular degeneration and age matched healthy donors. (2006) (127)
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (127)
Differential dependency network analysis to identify condition-specific topological changes in biological networks (2009) (123)
Dysferlin deficiency enhances monocyte phagocytosis: a model for the inflammatory onset of limb-girdle muscular dystrophy 2B. (2008) (121)
The rumpshaker mutation in spastic paraplegia (1994) (121)
Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression. (2004) (117)
rAAV vector-mediated sarcogylcan gene transfer in a hamster model for limb girdle muscular dystrophy (1999) (115)
Asynchronous remodeling is a driver of failed regeneration in Duchenne muscular dystrophy (2014) (114)
Functional characteristics of dystrophic skeletal muscle: insights from animal models. (2002) (114)
Molecular pathophysiology and targeted therapeutics for muscular dystrophy. (2001) (113)
ACE ID genotype and the muscle strength and size response to unilateral resistance training. (2006) (113)
Lamin A/C–mediated neuromuscular junction defects in Emery-Dreifuss muscular dystrophy (2009) (113)
Expression profiling reveals metabolic and structural components of extraocular muscles. (2002) (112)
Patterns of global gene expression in rat skeletal muscle during unloading and low-intensity ambulatory activity. (2003) (111)
Tissue-specific alternative splicing of TCF7L2 (2009) (110)
Balancing muscle hypertrophy and atrophy (2004) (109)
A role for mast cells in the progression of Duchenne muscular dystrophy? Correlations in dystrophin-deficient humans, dogs, and mice (1994) (109)
Associations between MeCP2 mutations, X-chromosome inactivation, and phenotype. (2002) (108)
Discovery of serum protein biomarkers in the mdx mouse model and cross-species comparison to Duchenne muscular dystrophy patients. (2014) (107)
Full Functional Rescue of a Complete Muscle (TA) in Dystrophic Hamsters by Adeno-Associated Virus Vector-Directed Gene Therapy (2000) (106)
Fgfr4 Is Required for Effective Muscle Regeneration in Vivo (2006) (106)
Genetic localization of a new locus for recessive familial spastic paraparesis to 15q13-15 (1999) (105)
Slug Is a Novel Downstream Target of MyoD (2002) (105)
Laminopathies disrupt epigenomic developmental programs and cell fate (2016) (105)
Congenital muscular dystrophy with primary laminin α2 (merosin) deficiency presenting as inflammatory myopathy (1996) (105)
Metabolite signatures of exercise training in human skeletal muscle relate to mitochondrial remodelling and cardiometabolic fitness (2014) (104)
Novel mutations in collagen VI genes: Expansion of the Bethlem myopathy phenotype (2002) (102)
Gene expression profiling of experimental traumatic spinal cord injury as a function of distance from impact site and injury severity. (2005) (102)
Sexual dimorphism in immune response genes as a function of puberty (2006) (100)
Restoring dystrophin expression in duchenne muscular dystrophy muscle progress in exon skipping and stop codon read through. (2011) (96)
Losartan Decreases Cardiac Muscle Fibrosis and Improves Cardiac Function in Dystrophin-Deficient Mdx Mice (2011) (96)
SPP1 genotype is a determinant of disease severity in Duchenne muscular dystrophy (2011) (95)
Olfactory biopsies demonstrate a defect in neuronal development in Rett's syndrome (2003) (94)
Safety, Tolerability, and Efficacy of Viltolarsen in Boys With Duchenne Muscular Dystrophy Amenable to Exon 53 Skipping (2020) (94)
Molecular findings in symptomatic and pre-symptomatic Alexander disease patients (2002) (93)
Proteome analysis of skeletal muscle from obese and morbidly obese women. (2005) (93)
The basal lamina is a physical barrier to herpes simplex virus-mediated gene delivery to mature muscle fibers (1996) (92)
Probe set algorithms: is there a rational best bet? (2006) (92)
Identification of Disease Specific Pathways Using in Vivo SILAC Proteomics in Dystrophin Deficient mdx Mouse* (2013) (91)
Direct analysis of lipids and small metabolites in mouse brain tissue by AP IR-MALDI and reactive LAESI mass spectrometry. (2010) (91)
Genetic epidemiology of muscular dystrophies resulting from sarcoglycan gene mutations. (1997) (90)
Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. (1999) (90)
Genetic modifiers of ambulation in the cooperative international Neuromuscular research group Duchenne natural history study (2015) (90)
DMD genotypes and loss of ambulation in the CINRG Duchenne Natural History Study (2016) (90)
In Vivo and in Vitro Characterization of Novel Neuronal Plasticity Factors Identified following Spinal Cord Injury* (2005) (89)
Multi-omic integrated networks connect DNA methylation and miRNA with skeletal muscle plasticity to chronic exercise in Type 2 diabetic obesity. (2014) (88)
Neuronal plasticity after spinal cord injury: identification of a gene cluster driving neurite outgrowth (2005) (88)
Skeletal muscle gene expression in response to resistance exercise: sex specific regulation (2010) (88)
The frequency of patients with dystrophin abnormalities in a limb‐girdle patient population (1991) (87)
Hyperandrogenism and manifesting heterozygotes for 21-hydroxylase deficiency. (1997) (87)
Definition of the unique human extraocular muscle allotype by expression profiling. (2005) (87)
Functional polymorphisms associated with human muscle size and strength. (2004) (86)
Genotype Associations With Increases In Blood Creatine Kinase And Myoglobin Following Intense Eccentric Exercise: 883 Board #105 9:00 AM ??? 10:30 AM (2005) (85)
Novel CLCN1 mutations with unique clinical and electrophysiological consequences. (2002) (85)
Elevated basic fibroblast growth factor in the serum of patients with Duchenne muscular dystrophy (1994) (84)
A Longitudinal, Integrated, Clinical, Histological and mRNA Profiling Study of Resistance Exercise in Myositis (2010) (83)
Dystrophin: the protein product of the Duchene muscular dystrophy locus. 1987. (1992) (82)
Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy. (1991) (82)
Metabolic remodeling agents show beneficial effects in the dystrophin-deficient mdx mouse model (2012) (82)
Resistance exercise training influences skeletal muscle immune activation: a microarray analysis. (2012) (81)
Importance of SPP1 genotype as a covariate in clinical trials in Duchenne muscular dystrophy (2012) (81)
Gene expression profiling of astrocytes from hyperammonemic mice reveals altered pathways for water and potassium homeostasis in vivo (2008) (80)
Prednisolone‐induced changes in dystrophic skeletal muscle (2005) (80)
Viral gene delivery to skeletal muscle: insights on maturation-dependent loss of fiber infectivity for adenovirus and herpes simplex type 1 viral vectors. (1997) (80)
The paradox of muscle hypertrophy in muscular dystrophy. (2012) (79)
Indian Agarwal megalencephalic leukodystrophy with cysts is caused by a common MLC1 mutation (2004) (79)
Natural progression of childhood asthma symptoms and strong influence of sex and puberty. (2014) (78)
A gene for a severe lethal form of X-linked arthrogryposis (X-linked infantile spinal muscular atrophy) maps to human chromosome Xp11.3-q11.2. (1995) (76)
RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. (1997) (76)
Congenital Titinopathy: Comprehensive characterization and pathogenic insights (2018) (75)
IGF-II gene region polymorphisms related to exertional muscle damage. (2007) (74)
Endothelial cell activation and neovascularization are prominent in dermatomyositis (2006) (73)
Forty-eight hours of unloading and 24 h of reloading lead to changes in global gene expression patterns related to ubiquitination and oxidative stress in humans. (2010) (73)
Metataxonomic and Metagenomic Approaches vs. Culture-Based Techniques for Clinical Pathology (2016) (73)
Extensive and prolonged restoration of dystrophin expression with vivo-morpholino-mediated multiple exon skipping in dystrophic dogs. (2012) (73)
Delayed inflammatory mRNA and protein expression after spinal cord injury (2011) (72)
Dystrophin-deficient myofibers are vulnerable to mast cell granule-induced necrosis (1994) (72)
Myotonia and the muscle chloride channel (1996) (72)
Expression of two temporally distinct microglia‐related gene clusters after spinal cord injury (2006) (71)
Relationships between circadian rhythms and modulation of gene expression by glucocorticoids in skeletal muscle. (2008) (71)
Asthmatic airway epithelium is intrinsically inflammatory and mitotically dyssynchronous. (2011) (71)
Chapter 8 The Animal Models of Duchenne Muscular Dystrophy: Windows on the Pathophysiological Consequences of Dystrophin Deficiency (1991) (70)
Congenital Muscular Dystrophy Overview (2012) (70)
Deletion of galectin-3 exacerbates microglial activation and accelerates disease progression and demise in a SOD1G93A mouse model of amyotrophic lateral sclerosis (2012) (69)
Herpes simplex virus vector‐mediated dystrophin gene transfer and expression in MDX mouse skeletal muscle (1999) (69)
Skipping toward personalized molecular medicine. (2007) (68)
Mutations that disrupt the carboxyl-terminus of gamma-sarcoglycan cause muscular dystrophy. (1996) (68)
CCL2 and CCR2 polymorphisms are associated with markers of exercise-induced skeletal muscle damage. (2010) (67)
Interleukin-15 and interleukin-15R alpha SNPs and associations with muscle, bone, and predictors of the metabolic syndrome. (2008) (67)
Homozygous α‐sarcoglycan mutation in two siblings: One asymptomatic and one steroid‐responsive mild limb–girdle muscular dystrophy patient (1998) (67)
Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway (2012) (66)
Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy (1995) (66)
Glucocorticoid-Treated Mice Are an Inappropriate Positive Control for Long-Term Preclinical Studies in the mdx Mouse (2012) (66)
Highly skewed X-chromosome inactivation is associated with idiopathic recurrent spontaneous abortion. (1999) (65)
Clinical utility of serum biomarkers in Duchenne muscular dystrophy (2016) (65)
Fluorescent multiplex linkage analysis and carrier detection for Duchenne/Becker muscular dystrophy. (1992) (63)
Evidence for the association of dystrophin with the transverse tubular system in skeletal muscle. (1988) (63)
Membrane Sealant Poloxamer P188 Protects Against Isoproterenol Induced Cardiomyopathy in Dystrophin Deficient Mice (2011) (63)
Exercise training increases electron and substrate shuttling proteins in muscle of overweight men and women with the metabolic syndrome. (2005) (62)
Massive muscle cell degeneration in the early stage of merosin-deficient congenital muscular dystrophy (2001) (62)
TNF-α-Induced microRNAs Control Dystrophin Expression in Becker Muscular Dystrophy. (2015) (62)
Is myoblast transplantation effective? (1998) (62)
A renaissance for antisense oligonucleotide drugs in neurology: exon skipping breaks new ground. (2009) (61)
Skeletal muscle dictates the fibrinolytic state after exercise training in overweight men with characteristics of metabolic syndrome (2003) (61)
Proteomic responses of skeletal and cardiac muscle to exercise (2011) (59)
Sepsis alters the megakaryocyte-platelet transcriptional axis resulting in granzyme B-mediated lymphotoxicity. (2009) (59)
Orphan drug development in muscular dystrophy: update on two large clinical trials of dystrophin rescue therapies. (2013) (59)
Evidence for a heterozygote advantage in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (1997) (59)
Diagnosis and etiology of congenital muscular dystrophy: We are halfway there (2016) (58)
Linkage of hyperkalaemic periodic paralysis in quarter horses to the horse adult skeletal muscle sodium channel gene. (2009) (58)
Dystrophin distribution in heterozygote mdx mice (1989) (58)
Limb-Girdle Muscular Dystrophy Overview (2012) (58)
Pilot study of myoblast transfer in the treatment of Becker muscular dystrophy (1998) (57)
Single-Molecule Long-Read 16S Sequencing To Characterize the Lung Microbiome from Mechanically Ventilated Patients with Suspected Pneumonia (2014) (56)
Differential expression of immunoregulatory genes in male and female Norway rats following infection with Seoul virus (2004) (56)
Phase IIa trial in Duchenne muscular dystrophy shows vamorolone is a first‐in‐class dissociative steroidal anti‐inflammatory drug (2018) (56)
A novel X chromosome-linked genetic cause of recurrent spontaneous abortion. (2001) (55)
Mathematical modelling of transcriptional heterogeneity identifies novel markers and subpopulations in complex tissues (2016) (55)
Gene expression and muscle fiber function in a porcine ICU model. (2009) (55)
Association Study of Exon Variants in the NF-κB and TGFβ Pathways Identifies CD40 as a Modifier of Duchenne Muscular Dystrophy. (2016) (54)
Targeted mutation of mouse skeletal muscle sodium channel produces myotonia and potassium-sensitive weakness. (2008) (54)
DNA microarray analysis of neonatal mouse lung connects regulation of KDR with dexamethasone-induced inhibition of alveolar formation. (2004) (54)
The PEPR GeneChip data warehouse, and implementation of a dynamic time series query tool (SGQT) with graphical interface (2004) (54)
Microarray analysis of the temporal response of skeletal muscle to methylprednisolone: comparative analysis of two dosing regimens. (2007) (54)
Progression of volume load and muscular adaptation during resistance exercise (2011) (54)
Mutations in the δ-sarcoglycan gene are a rare cause of autosomal recessive limb-girdle muscular dystrophy (LGMD2) (1997) (53)
Molecular genetics of familial spastic paraplegia: a multitude of responsible genes (1996) (52)
Recruitment of mast cells to muscle after mild damage (1996) (52)
Microarray analysis reveals novel features of the muscle aging process in men and women. (2013) (52)
Limb–Girdle and Congenital Muscular Dystrophies: Current Diagnostics, Management, and Emerging Technologies (2010) (52)
Novel approaches to corticosteroid treatment in Duchenne muscular dystrophy. (2012) (51)
Myostatin and follistatin polymorphisms interact with muscle phenotypes and ethnicity. (2009) (51)
Genetic and Clinical Heterogeneity in eIF2B-Related Disorder (2008) (51)
Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. (1999) (51)
Delivery of α- and β-Sarcoglycan by Recombinant Adeno-Associated Virus: Efficient Rescue of Muscle, but Differential Toxicity (2002) (51)
Autosomal recessive muscular dystrophy and mutations of the sarcoglycan complex (1996) (51)
The genomic structure of the human skeletal muscle sodium channel gene. (1992) (51)
PPARα L162V underlies variation in serum triglycerides and subcutaneous fat volume in young males (2007) (50)
Integrin α7β1 in Muscular Dystrophy/Myopathy of Unknown Etiology (2002) (49)
Laminin alpha2 muscular dystrophy: genotype/phenotype studies of 22 patients. (1998) (49)
Pharmacologic management of Duchenne muscular dystrophy: target identification and preclinical trials. (2014) (48)
MyoD Acetylation Influences Temporal Patterns of Skeletal Muscle Gene Expression* (2007) (48)
Vamorolone trial in Duchenne muscular dystrophy shows dose-related improvement of muscle function (2019) (48)
THE MUSCLE STRENGTH AND SIZE RESPONSE TO UPPER ARM,UNILATERAL RESISTANCE TRAINING AMONG ADULTS WHO ARE OVERWEIGHT AND OBESE (2007) (47)
Genetic Modifiers of Duchenne Muscular Dystrophy and Dilated Cardiomyopathy (2015) (47)
Sequence and genomic structure of the human adult skeletal muscle sodium channel alpha subunit gene on 17q. (1992) (47)
In vivo filtering of in vitro expression data reveals MyoD targets. (2003) (47)
Muscle maturation: implications for gene therapy. (1998) (47)
Clarifying the boundaries between the inflammatory and dystrophic myopathies: insights from molecular diagnostics and microarrays. (2002) (46)
A rippling muscle disease gene is localized to 1q41 (1994) (46)
Voltage-gated ion channelopathies: inherited disorders caused by abnormal sodium, chloride, and calcium regulation in skeletal muscle. (1995) (46)
A C‐terminal skeletal muscle sodium channel mutation associated with myotonia disrupts fast inactivation (2005) (45)
VBP15: preclinical characterization of a novel anti-inflammatory delta 9,11 steroid. (2013) (45)
Accurate Quantitation of Dystrophin Protein in Human Skeletal Muscle Using Mass Spectrometry. (2012) (45)
Detection of a specific isoform of alpha-actinin with antisera directed against dystrophin (1989) (45)
Decreased asialotransferrin in cerebrospinal fluid of patients with childhood-onset ataxia and central nervous system hypomyelination/vanishing white matter disease. (2005) (45)
Laryngeal and pharyngeal dysfunction in horses homozygous for hyperkalemic periodic paralysis. (1996) (44)
Evidence for ACTN3 as a genetic modifier of Duchenne muscular dystrophy (2017) (44)
CROSS-REACTIVE PROTEIN IN DUCHENNE MUSCLE (1989) (44)
Clinical and molecular study in congenital muscular dystrophy with partial laminin α2 (LAMA2) deficiency (2003) (44)
Regional localization of the murine Duchenne muscular dystrophy gene on the mouse X chromosome (1987) (43)
Phenotypic heterogeneity associated with the splicing mutation in congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (1996) (43)
Alterations in osteopontin modify muscle size in females in both humans and mice. (2013) (43)
X-inactivation patterns in female Leber's hereditary optic neuropathy patients do not support a strong X-linked determinant. (1996) (43)
Genotype/phenotype correlations in Duchenne/Becker dystrophy. (1993) (43)
Pathophysiology of sodium channelopathies: correlation of normal/mutant mRNA ratios with clinical phenotype in dominantly inherited periodic paralysis. (1994) (42)
PCB congener specific oxidative stress response by microarray analysis using human liver cell line. (2010) (42)
DDN: a caBIG® analytical tool for differential network analysis (2011) (42)
Murine Cytomegalovirus Infection Increases Aortic Expression of Proatherosclerotic Genes (2003) (42)
Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the mdx Mouse Model of Duchenne Muscular Dystrophy (2010) (42)
Duchenne/Becker muscular dystrophy: a short overview of the gene, the protein, and current diagnostics. (1989) (42)
Phase 1 trial of vamorolone, a first-in-class steroid, shows improvements in side effects via biomarkers bridged to clinical outcomes (2018) (42)
Erratum: Calorie-related rapid onset of alveolar loss, regeneration, and changes in mouse lung gene expression (American Journal of Physiology - Lung Cellular and Molecular Physiology (May 2004) 30 (L896-L906)) (2004) (42)
Rhinovirus infection in young children is associated with elevated airway TSLP levels (2014) (41)
Intracellular expression profiling by laser capture microdissection: three novel components of the neuromuscular junction. (2005) (41)
Phospholipase A2 activity in dystrophinopathies (1995) (41)
CCL2 and CCR2 variants are associated with skeletal muscle strength and change in strength with resistance training. (2010) (41)
Hyperkalemic periodic paralysis (1993) (40)
Clinical Variability in Rett Syndrome (2003) (40)
Analysis of the toxicogenomic effects of exposure to persistent organic pollutants (POPs) in Slovakian girls: correlations between gene expression and disease risk. (2012) (40)
Confirmation of linkage of hyperkalaemic periodic paralysis to chromosome 17. (1991) (40)
Role of the nerve in determining fetal skeletal muscle phenotype (1998) (40)
Antisense oligo-mediated multiple exon skipping in a dog model of duchenne muscular dystrophy. (2011) (40)
Dysferlin deficiency shows compensatory induction of Rab27A/Slp2a that may contribute to inflammatory onset. (2008) (40)
Sparing of the dystrophin-deficient cranial sartorius muscle is associated with classical and novel hypertrophy pathways in GRMD dogs. (2013) (40)
Membrane Stabilization by Modified Steroid Offers a Potential Therapy for Muscular Dystrophy Due to Dysferlin Deficit (2018) (40)
A randomized clinical trial to assess the effect of statins on skeletal muscle function and performance: rationale and study design. (2010) (39)
MR imaging findings in children with merosin-deficient congenital muscular dystrophy. (1999) (39)
Guidelines: Expression profiling — best practices for data generation and interpretation in clinical trials (2004) (39)
Enormous dystrophin in a patient with Becker muscular dystrophy (1990) (38)
Differential gene expression and a functional analysis of PCB-exposed children: understanding disease and disorder development. (2012) (38)
Molecular genetics of Duchenne and Becker muscular dystrophy: emphasis on improved diagnosis. (1989) (38)
Identification of Pathway-Specific Serum Biomarkers of Response to Glucocorticoid and Infliximab Treatment in Children with Inflammatory Bowel Disease (2016) (38)
Deficiency of different nitric oxide synthase isoforms activates divergent transcriptional programs in cardiac hypertrophy. (2003) (38)
Resistin Polymorphisms Are Associated with Muscle, Bone, and Fat Phenotypes in White Men and Women (2007) (38)
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle (2017) (38)
Optimized multilayer perceptrons for molecular classification and diagnosis using genomic data (2006) (37)
Characterization of Dysferlin Deficient SJL/J Mice to Assess Preclinical Drug Efficacy: Fasudil Exacerbates Muscle Disease Phenotype (2010) (37)
Report of a TREAT-NMD/World Duchenne Organisation Meeting on Dystrophin Quantification Methodology (2019) (36)
Time series proteome profiling to study endoplasmic reticulum stress response. (2008) (36)
Neck and waist circumference biomarkers of cardiovascular risk in a cohort of predominantly African-American college students: a preliminary study. (2014) (36)
Differences in fat and muscle mass associated with a functional human polymorphism in a post‐transcriptional BMP2 gene regulatory element (2009) (36)
Adiposity attenuates muscle quality and the adaptive response to resistance exercise in non-obese, healthy adults (2011) (36)
Dystrophin and disease. (1991) (35)
A novel mutation expands the genetic and clinical spectrum of MYH7-related myopathies (2013) (35)
Vamorolone targets dual nuclear receptors to treat inflammation and dystrophic cardiomyopathy (2019) (35)
Genetic and molecular aspects of sport performance (2011) (35)
Serum pharmacodynamic biomarkers for chronic corticosteroid treatment of children (2016) (35)
The ACTN3 R577X Polymorphism Is Associated with Cardiometabolic Fitness in Healthy Young Adults (2015) (34)
miRTarVis: an interactive visual analysis tool for microRNA-mRNA expression profile data (2015) (34)
Mechanisms underlying the sparing of masticatory versus limb muscle function in an experimental critical illness model. (2011) (34)
Dystrophin analysis in duchenne muscular dystrophy: use in fetal diagnosis and in genetic counseling. (1989) (34)
HyperCKemic, proximal muscular dystrophies and the dystrophin membrane cytoskeleton, including dystrophinopathies, sarcoglycanopathies, and merosinopathies. (1996) (34)
Alpha-sarcoglycan deficiency featuring exercise intolerance and myoglobinuria. (2002) (33)
Pathophysiology of sodium channelopathies. Studies of sodium channel expression by quantitative multiplex fluorescence polymerase chain reaction. (1994) (33)
Exon-Skipping Therapy: A Roadblock, Detour, or Bump in the Road? (2014) (33)
Genome-wide identification of significant aberrations in cancer genome (2012) (33)
Unique PABP2 mutations in "Cajuns" suggest multiple founders of oculopharyngeal muscular dystrophy in populations with French ancestry. (1999) (33)
Molecular biology of Duchenne muscular dystrophy (1988) (33)
Toward fully automated genotyping: allele assignment, pedigree construction, phase determination, and recombination detection in Duchenne muscular dystrophy. (1994) (33)
Delivery of alpha- and beta-sarcoglycan by recombinant adeno-associated virus: efficient rescue of muscle, but differential toxicity. (2002) (32)
Global gene expression and Ingenuity biological functions analysis on PCBs 153 and 138 induced human PBMC in vitro reveals differential mode(s) of action in developing toxicities. (2011) (32)
The glucocorticoid receptor N363S polymorphism and steroid response in Duchenne dystrophy (2006) (32)
AKT1 polymorphisms are associated with risk for metabolic syndrome (2010) (31)
Moderate-intensity aerobic training program improves insulin sensitivity and inflammatory markers in a pilot study of morbidly obese minority teens. (2013) (31)
Current status of genetic discoveries in migraine: familial hemiplegic migraine and beyond. (1998) (31)
Genetic counseling of isolated carriers of Duchenne muscular dystrophy. (1996) (31)
A robust in vitro screening assay to identify NF-kappaB inhibitors for inflammatory muscle diseases. (2009) (30)
Proteomics and Systems Biology in Exercise and Sport Sciences Research (2007) (30)
X-linked infantile spinal muscular atrophy: Clinical definition and molecular mapping (2007) (30)
Interactive color mosaic and dendrogram displays for signal/noise optimization in microarray data analysis (2003) (29)
Rapid onset of gene expression in lung, supportive of formation of alveolar septa, induced by refeeding mice after calorie restriction. (2007) (29)
Elusive sources of variability of dystrophin rescue by exon skipping (2015) (29)
Transcriptional deficits in oxidative phosphorylation with statin myopathy (2011) (29)
INSIG2 gene polymorphism is associated with increased subcutaneous fat in women and poor response to resistance training in men (2008) (29)
α-Sarcoglycan (adhalin) deficiency: complete deficiency patients are 5% of childhood-onset dystrophin-normal muscular dystrophy and most partial deficiency patients do not have gene mutations (1996) (29)
Dystrophin analysis in clonal myoblasts derived from a Duchenne muscular dystrophy carrier. (1989) (29)
Non-invasive Optical Imaging of Muscle Pathology in mdx Mice Using Cathepsin Caged Near-Infrared Imaging (2010) (28)
A polymorphism near IGF1 is associated with body composition and muscle function in women from the Health, Aging, and Body Composition Study (2010) (28)
Subcutaneous fat alterations resulting from an upper-body resistance training program. (2007) (28)
Duchenne and Becker muscular dystrophies: genetics, prenatal diagnosis, and future prospects. (1990) (28)
Impaired autophagy, chaperone expression, and protein synthesis in response to critical illness interventions in porcine skeletal muscle. (2013) (27)
Novel Col12A1 variant expands the clinical picture of congenital myopathies with extracellular matrix defects (2017) (27)
Efficacy and safety of vamorolone in Duchenne muscular dystrophy: An 18-month interim analysis of a non-randomized open-label extension study (2020) (27)
Integrin alpha 7 beta 1 in muscular dystrophy/myopathy of unknown etiology. (2002) (27)
Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing. (2008) (27)
In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy. (1991) (27)
CNTF 1357 G -> A polymorphism and the muscle strength response to resistance training. (2009) (26)
Δ-9,11 Modification of Glucocorticoids Dissociates Nuclear Factor-κB Inhibitory Efficacy from Glucocorticoid Response Element-Associated Side Effects (2012) (26)
Knowledge-fused differential dependency network models for detecting significant rewiring in biological networks (2013) (26)
Exome Sequencing Identifies DYNC1H1 Variant Associated With Vertebral Abnormality and Spinal Muscular Atrophy With Lower Extremity Predominance. (2015) (26)
Motif-directed network component analysis for regulatory network inference (2007) (26)
Molecular diagnosis of 21-hydroxylase deficiency: detection of four mutations on a single gel. (1994) (26)
TGFBR2 but not SPP1 genotype modulates osteopontin expression in Duchenne muscular dystrophy muscle (2012) (25)
Rapid genotyping of common MeCP2 mutations with an electronic DNA microchip using serial differential hybridization. (2003) (25)
Muscle miRNAome shows suppression of chronic inflammatory miRNAs with both prednisone and vamorolone (2018) (25)
Duchenne-Becker muscular dystrophy and the nondystrophic myotonias. Paradigms for loss of function and change of function of gene products. (1993) (25)
Knowledge-guided multi-scale independent component analysis for biomarker identification (2008) (24)
Recent advances in dystrophin research (1991) (24)
Alpha-sarcoglycanopathy presenting as exercise intolerance and rhabdomyolysis in two adults (2015) (24)
In vivo multi-tissue corticosteroid microarray time series available online at Public Expression Profile Resource (PEPR). (2003) (24)
The use of urinary and kidney SILAM proteomics to monitor kidney response to high dose morpholino oligonucleotides in the mdx mouse (2015) (24)
Myoblast Transplantation: What's Going on? (1993) (24)
Leptin and leptin receptor genetic variants associate with habitual physical activity and the arm body composition response to resistance training. (2012) (24)
Short Read (Next-Generation) Sequencing: A Tutorial With Cardiomyopathy Diagnostics as an Exemplar (2013) (24)
Automated sequence screening of the entire dystrophin cdna in Duchenne dystrophy: Point mutation detection (2006) (24)
Highlights from the Functional Single Nucleotide Polymorphisms Associated with Human Muscle Size and Strength or FAMuSS Study (2013) (24)
Disease-specific and glucocorticoid-responsive serum biomarkers for Duchenne Muscular Dystrophy (2019) (24)
Gene Selection for Multiclass Prediction by Weighted Fisher Criterion (2007) (23)
Allometric scaling of isometric biceps strength in adult females and the effect of body mass index (2008) (23)
Eccentric muscle challenge shows osteopontin polymorphism modulation of muscle damage (2014) (23)
Sex Chromosome Genetics '99. The X chromosome and recurrent spontaneous abortion: the significance of transmanifesting carriers. (1999) (23)
SLC30A8 Nonsynonymous Variant Is Associated With Recovery Following Exercise and Skeletal Muscle Size and Strength (2013) (23)
Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study (2016) (23)
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy (2020) (23)
PUGSVM: a caBIGTM analytical tool for multiclass gene selection and predictive classification (2011) (22)
Non-Invasive MRI and Spectroscopy of mdx Mice Reveal Temporal Changes in Dystrophic Muscle Imaging and in Energy Deficits (2014) (22)
Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages (2015) (22)
Sensitivity and specificity of decreased CSF asialotransferrin for eIF2B-related disorder (2008) (22)
Investigation of gene expression in C(2)C(12) myotubes following simvastatin application and mechanical strain. (2009) (22)
Transcriptional profiling and biological pathway analysis of human equivalence PCB exposure in vitro: indicator of disease and disorder development in humans. (2015) (22)
Differential Gene Expression Reveals Mitochondrial Dysfunction in an Imprinting Center Deletion Mouse Model of Prader–Willi Syndrome (2013) (22)
Muscular dystrophy: identification and use of genes for diagnostics and therapeutics. (1999) (22)
The effects of MyD88 deficiency on disease phenotype in dysferlin‐deficient A/J mice: role of endogenous TLR ligands (2013) (22)
The proteome survey of an electricity‐generating organ (Torpedo californica electric organ) (2007) (22)
Erratum: β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex (Nature Genetics (1995) 11 266-273)) (1996) (21)
Large-scale disruption of microtubule pathways in morphologically normal human spastin muscle (2004) (21)
Molecular heterogeneity of glucose-6-phosphate dehydrogenase deficiency in Jordan. (2005) (21)
Linkage data suggesting allelic heterogeneity for paramyotonia congenita and hyperkalemic periodic paralysis on chromosome 17 (1991) (21)
Plasma membrane cytoskeleton of muscle: a fine structural analysis (2000) (21)
Somatic mosaicism for Duchenne dystrophy: Evidence for genetic normalization mitigating muscle symptoms (2009) (21)
Collaborative translational research leading to multicenter clinical trials in Duchenne muscular dystrophy: the Cooperative International Neuromuscular Research Group (CINRG) (2002) (21)
Gene Module Identification from Microarray Data Using Nonnegative Independent Component Analysis (2008) (21)
OPN‐a induces muscle inflammation by increasing recruitment and activation of pro‐inflammatory macrophages (2016) (21)
Genetic modifiers of respiratory function in Duchenne muscular dystrophy (2020) (21)
A long-read RNA-seq approach to identify novel transcripts of very large genes (2020) (21)
Fetal Muscle Biopsy: Collaborative Experience With Varied Indications (1994) (21)
Muscle histology in becker muscular dystrophy (1991) (20)
VBP15, a Glucocorticoid Analogue, Is Effective at Reducing Allergic Lung Inflammation in Mice (2013) (20)
Physical mapping of the rippling muscle disease locus. (1999) (20)
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis (2015) (20)
caBIG™ VISDA: Modeling, visualization, and discovery for cluster analysis of genomic data (2008) (20)
MC4R Variant Is Associated With BMI but Not Response to Resistance Training in Young Females (2011) (20)
Immunopathogenic pathways in canine inflammatory myopathies resemble human myositis. (2006) (20)
Confocal analysis of the dystrophin protein complex in muscular dystrophy (2001) (20)
Role of sepsis in the development of limb muscle weakness in a porcine intensive care unit model. (2012) (19)
Multilevel support vector regression analysis to identify condition-specific regulatory networks (2010) (19)
Evaluation of Skeletal and Cardiac Muscle Function after Chronic Administration of Thymosin β-4 in the Dystrophin Deficient Mouse (2010) (19)
In utero fetal muscle biopsy for the diagnosis of Duchenne muscular dystrophy in a female fetus "suddenly at risk". (1993) (19)
Molecular diagnosis and modern management of Duchenne muscular dystrophy. (1994) (19)
Matched Gene Selection and Committee Classifier for Molecular Classification of Heterogeneous Diseases (2010) (19)
Translating mighty mice into neuromuscular therapeutics: is bigger muscle better? (2006) (18)
The Evolving Genome Project: current and future impact. (1994) (18)
Glucocorticoid Efficacy in Asthma (2010) (18)
In vivo sodium channel structure/function studies: consecutive Arg1448 changes to Cys, His, and Pro at the extracellular surface of IVS4. (1995) (18)
KDDN: an open-source Cytoscape app for constructing differential dependency networks with significant rewiring (2015) (18)
17 alpha-hydroxylase/17,20-lyase dysregulation is not caused by mutations in the coding regions of CYP17. (1998) (18)
The Calculation of Genetic Risks: Worked Examples in DNA Diagnostics (1995) (18)
Tissue-specific alternative splicing of TCF 7 L 2 (2009) (17)
Developmental Pharmacodynamics and Modeling in Pediatric Drug Development (2019) (17)
Serum biomarkers of glucocorticoid response and safety in anti-neutrophil cytoplasmic antibody-associated vasculitis and juvenile dermatomyositis (2018) (17)
Targeted Re-Sequencing Emulsion PCR Panel for Myopathies: Results in 94 Cases. (2016) (17)
Disruption of a key ligand-H-bond network drives dissociative properties in vamorolone for Duchenne muscular dystrophy treatment (2020) (17)
miRTarVis+: Web-based interactive visual analytics tool for microRNA target predictions. (2017) (17)
Recessive ACTA1 variant causes congenital muscular dystrophy with rigid spine (2014) (17)
Neonatal screening for Duchenne/Becker muscular dystrophy; Reconsideration based on molecular diagnosis and potential therapeutics (1992) (17)
X inactivation and dystrophin studies in a t(X;12) female: evidence for biochemical normalization in Duchenne muscular dystrophy carriers. (1992) (17)
Musculin isoforms and repression of MyoD in muscle regeneration. (2006) (17)
Asymptomatic dystrophinopathy. (1997) (17)
Motif-guided sparse decomposition of gene expression data for regulatory module identification (2011) (17)
Delineation of a Gene Network Underlying the Pulmonary Response to Oxidative Stress in Asthma (2009) (16)
Integrated genomics and proteomics of the Torpedo californica electric organ: concordance with the mammalian neuromuscular junction (2011) (16)
The discovery of dystrophin, the protein product of the Duchenne muscular dystrophy gene (2020) (16)
Variants of the Ankyrin Repeat Domain 6 Gene (ANKRD6) and Muscle and Physical Activity Phenotypes Among European-Derived American Adults (2012) (16)
Muscle Weakness in Myositis: MicroRNA‐Mediated Dystrophin Reduction in a Myositis Mouse Model and Human Muscle Biopsies (2020) (16)
NKG2A and CD56 are coexpressed on activated TH2 but not TH1 lymphocytes. (2005) (16)
Nondisease genetic testing: reporting of muscle SNPs shows effects on self-concept and health orientation scales (2005) (16)
Molecular studies of progressive muscular dystrophy (Duchenne). (1987) (16)
Characterization of Transferrin Glycopeptide Structures in Human Cerebrospinal Fluid. (2012) (16)
Obesity-Related Genetic Variants and their Associations with Physical Activity (2015) (16)
Allometric scaling of biceps strength before and after resistance training in men. (2007) (16)
Detection of Nonrandom X Chromosome Inactivation (2002) (16)
GeneShelf: A Web-based Visual Interface for Large Gene Expression Time-Series Data Repositories (2009) (15)
Book Review Mitochondrial Disorders in Neurology (Butterworth–Heinemann International Medical Reviews. No. 14.) Edited by Anthony H.V. Schapira and S. DiMauro. 254 pp. Boston, Butterworth–Heinemann, 1994. $75. 0-7506-0585-5 (1995) (15)
Mitotic asynchrony induces transforming growth factor-β1 secretion from airway epithelium. (2014) (15)
Private β‐ and γ‐sarcoglycan gene mutations: Evidence of a founder effect in Northern Italy (2000) (15)
Functional recovery of glycine receptors in spastic murine model of startle disease (2006) (15)
The 1p13.3 LDL (C)-Associated Locus Shows Large Effect Sizes in Young Populations (2011) (15)
Eps homology domain endosomal transport proteins differentially localize to the neuromuscular junction (2012) (15)
Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy (2022) (14)
Mexiletine for treatment of myotonia: a trial triumph for rare disease networks. (2012) (14)
Restoration of half the normal dystrophin sequence in a double-deletion Duchenne muscular dystrophy family. (1994) (14)
Morpholino‐induced exon skipping stimulates cell‐mediated and humoral responses to dystrophin in mdx mice (2019) (14)
Association of Age with Muscle Size and Strength Before and After Short-Term Resistance Training in Young Adults (2009) (14)
The genetics of muscle atrophy and growth: the impact and implications of polymorphisms in animals and humans. (2005) (14)
In vivo filtering of in vitro MyoD target data: An approach for identification of biologically relevant novel downstream targets of transcription factors (2003) (2005) (14)
Duchenne muscular dystrophy (Oxford monographs on medical genetics, Vol. 15) (revised edn): A.E.H. Emery, Oxford University Press, 1988. £17.50 (xv + 317 pages) ISBN 0 19 261798 2 (1989) (13)
Functional characterization of a haplotype in the AKT1 gene associated with glucose homeostasis and metabolic syndrome (2010) (13)
Pharmacotherapy of Duchenne Muscular Dystrophy. (2019) (13)
Neurodevelopmental Needs in Young Boys with Duchenne Muscular Dystrophy (DMD): Observations from the Cooperative International Neuromuscular Research Group (CINRG) DMD Natural History Study (DNHS). (2018) (13)
Differences in gene expression profiles in dermal fibroblasts from control and patients with age-related macular degeneration elicited by oxidative injury. (2005) (13)
CYP1A1 and MT1K are congener specific biomarker genes for liver diseases induced by PCBs. (2008) (13)
Muscle myeloid type I interferon gene expression may predict therapeutic responses to rituximab in myositis patients. (2016) (13)
Vascular remodeling in response to 12 wk of upper arm unilateral resistance training. (2009) (13)
Causes of clinical variability in Duchenne and Becker muscular dystrophies and implications for exon skipping therapies (2020) (13)
Desminopathies: Good stuff lost, garbage gained, or the trashman misdirected? (2003) (13)
Effects of corticosteroids in the development of limb muscle weakness in a porcine intensive care unit model. (2013) (13)
Hemiplegic migraine--downstream of a single-base change. (2001) (13)
Ion channels--molecular divining rods hit their clinical mark. (1997) (12)
Correction: Sphingosine-1-Phosphate Enhances Satellite Cell Activation in Dystrophic Muscles through a S1PR2/STAT3 Signaling Pathway (2012) (12)
Osteopontin is linked with AKT, FoxO1, and myostatin in skeletal muscle cells (2017) (12)
Effect of the SORT1 low-density lipoprotein cholesterol locus is sex-specific in a fit, Canadian young-adult population. (2013) (12)
Duchenne muscular dystrophy (1992) (11)
A novel laminin alpha2 isoform in severe laminin alpha2 deficient congenital muscular dystrophy. (2000) (11)
Serum biomarkers associated with baseline clinical severity in young steroid-naïve Duchenne muscular dystrophy boys (2020) (11)
226th ENMC International Workshop: Towards validated and qualified biomarkers for therapy development for Duchenne muscular dystrophy 20–22 January 2017, Heemskerk, The Netherlands (2018) (11)
Proteomic profiling of glucocorticoid-exposed myogenic cells: Time series assessment of protein translocation and transcription of inactive mRNAs (2009) (11)
Global Gene Profiling of VCP‐associated Inclusion Body Myopathy (2012) (11)
Molecular Basis of Neuromuscular Disease (1998) (11)
Status of LEPR Gene in PCB-exposed Population: A Quick Look (2013) (11)
Absolute Quantification of Dystrophin Protein in Human Muscle Biopsies using Parallel Reaction Monitoring (PRM). (2020) (11)
Human muscle stem cells are refractory to aging (2020) (11)
Genetic and Molecular Aspects of Sport Performance: Bouchard/Genetic and Molecular Aspects of Sport Performance (2011) (10)
Counting muscular dystrophies in the post-molecular census (1999) (10)
Development and production of an oligonucleotide MuscleChip: use for validation of ambiguous ESTs (2002) (10)
Optimizing signal / noise ratios in expression profiling : Project-specific algorithm selection and detection p value weighting in Affymetrix microarrays (2004) (10)
African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks (2017) (10)
Long-Term Functional Efficacy and Safety of Viltolarsen in Patients with Duchenne Muscular Dystrophy (2022) (9)
Proximal myopathy with focal depletion of mitochondria and megaconial congenital muscular dystrophy are allelic conditions caused by mutations in CHKB (2016) (9)
Expression profiling and pharmacogenomics of muscle and muscle disease. (2003) (9)
Robust feature selection by weighted Fisher criterion for multiclass prediction in gene expression profiling (2004) (9)
Homozygous mutation in Atlastin GTPase 1 causes recessive hereditary spastic paraplegia (2016) (9)
Prenatal diagnosis of Duchenne muscular dystrophy by fetal muscle biopsy (1992) (9)
Knowledge-guided gene ranking by coordinative component analysis (2010) (9)
Biomarker Identification by Knowledge-Driven Multi-Level ICA and Motif Analysis (2007) (9)
Glucocorticoid Receptor (NR3C1) Variants Associate with the Muscle Strength and Size Response to Resistance Training (2016) (9)
New molecular research technologies in the study of muscle disease (2003) (9)
Examination of Lifestyle Behaviors and Cardiometabolic Risk Factors in University Students Enrolled in Kinesiology Degree Programs (2016) (9)
Dystrophin associated proteins fail in filling dystrophin's shoes (1994) (8)
Molecular diagnostics of Duchenne/Becker dystrophy: New additions to a rapidly expanding literature (1991) (8)
Orthogonal analysis of dystrophin protein and mRNA as a surrogate outcome for drug development. (2019) (8)
Erratum: Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (8)
The Relationship between Coronary Artery Disease Risk Factors and Carotid Intima‐Media Thickness in Children (2017) (8)
Additional dystrophin fragment in Becker muscular dystrophy may result from proteolytic cleavage at deletion junctions. (1992) (8)
Expression of macrophage genes within skeletal muscle correlates inversely with adiposity and insulin resistance in humans. (2018) (8)
The CAM software for nonnegative blind source separation in R-Java (2013) (8)
In utero fetal muscle biopsy alters diagnosis and carrier risks in Duchenne and Becker muscular dystrophy. (1995) (8)
Strength, Size, and Muscle Quality in the Upper Arm following Unilateral Training in Younger and Older Males and Females (2009) (8)
Stability-Based Dimension Estimation of ICA with Application to Microarray Data Analysis (2007) (7)
A calm before the exome storm (2012) (7)
A ground truth based comparative study on clustering of gene expression data. (2008) (7)
Endoscopically assisted, ultrasound-guided fetal muscle biopsy. (1995) (7)
Variable histological expression of dystrophinopathy in two females (1999) (7)
Population Pharmacokinetics of Vamorolone (VBP15) in Healthy Men and Boys With Duchenne Muscular Dystrophy (2019) (7)
The ACTN 3 R 577 X Polymorphism Is Associated with Cardiometabolic Fitness in Healthy Young Adults (2017) (7)
Gene complementation using myoblast transfer into fetal muscle. (1994) (7)
MicroRNA Profiling in Adipose Before and After Weight Loss Highlights the Role of miR‐223‐3p and the NLRP3 Inflammasome (2020) (7)
Genetic modifiers of ambulation in the CINRG duchenne natural history study. (2015) (6)
Characterization of the ZBTB42 gene in humans and mice (2010) (6)
Genetic Variation in Acid Ceramidase Predicts Non-completion of an Exercise Intervention (2018) (6)
Correction: Discovery of Metabolic Biomarkers for Duchenne Muscular Dystrophy within a Natural History Study (2016) (6)
A severe case of Duchenne-like muscular dystrophy due to a mutation in the alpha-sarcoglycan (adhalin) gene (1996) (6)
Phenotypic-Specific Gene Module Discovery using a Diagnostic Tree and caBIGTM VISDA (2006) (6)
Evolution and comparative genomics of subcellular specializations: EST sequencing of Torpedo electric organ. (2011) (6)
Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy (2021) (6)
A rebirth for drisapersen in Duchenne muscular dystrophy? (2014) (6)
Exon-Skipping in Duchenne Muscular Dystrophy (2021) (6)
Discovery of potential urine-accessible metabolite biomarkers associated with muscle disease and corticosteroid response in the mdx mouse model for Duchenne (2019) (6)
A genetic variant in IL‐15Rα correlates with physical activity among European–American adults (2018) (5)
Gene expression dissection by non-negative well-grounded source separation (2008) (5)
A polymorphism near IGF 1 is associated with body composition and muscle function in women from the Health , Aging , and Body Composition Study (2010) (5)
Human molecular genetics and the elucidation of the primary biochemical defect in Duchenne muscular dystrophy. (1989) (5)
Mechanisms of allelic and clinical heterogeneity of lamin A/C phenotypes (2018) (5)
Exposure‐Response Analysis of Vamorolone (VBP15) in Boys With Duchenne Muscular Dystrophy (2020) (5)
Secreted Proteome Profiling in Human RPE Cell Cultures Derived from Donors with Age Related Macular Degeneration and Age Matched Healthy Donors J. Proteome Res. 2006, 5, 2599−2610. (2007) (5)
Sphingosine-1-phosphate enhances satellite cell activation in dystrophic muscles through a S 1 PR 2 / STAT 3 signaling pathway (2016) (5)
Dystrophin-positive myotubes in innervated muscle cultures from Duchenne and Becker muscular dystrophy patients (1993) (5)
Computational Analysis of Muscular Dystrophy Sub-types Using a Novel Integrative Scheme (2010) (5)
Identification of Condition-specific Regulatory Modules by Multi-level Motif and mRNA Expression Analysis (2008) (5)
Normalization of microarray data by iterative nonlinear regression (2005) (5)
Somatic mosaicism due to a reversion variant causing hemi-atrophy: a novel variant of dystrophinopathy (2016) (5)
Expression Profiling in the Muscular Dystrophies (2000) (5)
Duchenne muscular dystrophy and myotonic dystrophy in the same patient. (1995) (5)
Latent Variable and nICA Modeling of Pathway Gene Module Composite (2006) (5)
A Dystrophin Exon-52 Deleted Miniature Pig Model of Duchenne Muscular Dystrophy and Evaluation of Exon Skipping (2021) (5)
Influence of β2 adrenergic receptor genotype on risk of nocturnal ventilation in patients with Duchenne muscular dystrophy (2019) (5)
Blunted circadian cortisol in children is associated with poor cardiovascular health and may reflect circadian misalignment (2021) (5)
Supplemental Data Glucose Restriction Inhibits Skeletal Myoblast Differentiation by Activating SIRT 1 through AMPK-Mediated Regulation of Nampt (2008) (5)
Response to Comment on Sprouse et al. SLC30A8 Nonsynonymous Variant Is Associated With Recovery Following Exercise and Skeletal Muscle Size and Strength. Diabetes 2014;63:363–368 (2014) (5)
Allelic heterogeneity of lamin A/C phenotypes and molecular mechanism behind it (2018) (5)
Pharmacodynamic/Pharmacogenomic Modeling of Insulin Resistance Genes in Rat Muscle After Methylprednisolone Treatment: Exploring Regulatory Signaling Cascades (2008) (5)
Genetic characterization of physical activity behaviours in university students enrolled in kinesiology degree programs. (2017) (5)
The angiotensin‐converting enzyme insertion/deletion polymorphism rs4340 associates with habitual physical activity among European American adults (2017) (4)
Efficacy and Safety of Vamorolone vs Placebo and Prednisone Among Boys With Duchenne Muscular Dystrophy (2022) (4)
Mechanism of action and therapeutic route for a muscular dystrophy caused by a genetic defect in lipid metabolism (2022) (4)
Biomarker-focused multi-drug combination therapy and repurposing trial in mdx mice (2021) (4)
P.27 Association study of exome variants in the NF-κB and TGFβ pathways identifies CD40 as a modifier of Duchenne muscular dystrophy (2016) (4)
CorrigendumCorrigendum to “VBP15: Preclinical characterization of a novel anti-inflammatory delta 9,11 steroid” [Bioorg. Med. Chem. 21 (2013) 2241–2249] (2015) (4)
Proceedings of a Parent Project Muscular Dystrophy Bone Health Workshop Morbidity due to osteoporosis in DMD: The Path Forward May 12–13, 2016, Bethesda, Maryland, USA (2018) (4)
Pyruvate Dehydrogenase Phosphatase Regulatory Gene Expression Correlates with Exercise Training Insulin Sensitivity Changes. (2016) (4)
Neuro-oncology: Understanding the molecular complexity of medulloblastoma (2012) (4)
Endothelial Nitric Oxide Synthase (NOS3) +894 G>T Associates with Physical Activity and Muscle Performance among Young Adults (2012) (4)
Prednisone/prednisolone and deflazacort differ in long term outcomes on ambulation and side effects in the CINRG Duchenne Natural History Study (S50.001) (2015) (4)
Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2017) (3)
Molecular basis of neuromuscular diseases. (1998) (3)
Huntington's Disease: Their loss is our gain? (1995) (3)
The Influence of Metabolic Syndrome Risk Factors on Carotid Intima Media Thickness in Children (2021) (3)
Exploring Transcriptional Modules Through Integrative Gene Clustering Guided by Transcription Factor Binding Information (2008) (3)
Acute serum protein and cytokine response of single dose of prednisone in adult volunteers (2022) (3)
Transcriptional Cascades in Muscle Regeneration (2008) (3)
Molecular and cytogenetic studies of X inactivation in a patient with 46,X,del(X)(q22). (1997) (3)
Integrated Identification of Disease Specific Pathways Using Multi-omics data (2019) (3)
Limb girdle muscular dystrophy (2018) (3)
Molecular Pathogenesis of Genetic and Inherited Diseases Dysferlin Deficiency Shows Compensatory Induction of Rab 27 A / Slp 2 a That May Contribute to Inflammatory Onset (2010) (3)
Global Gene Expression Profiling in R155H Knock‐In Murine Model of VCP Disease (2015) (3)
Application of Scaling Factors in Simultaneous Modeling of Microarray Data from Diverse Chips (2007) (3)
The Proton Pump Inhibitor Lansoprazole Improves the Skeletal Phenotype in Dystrophin Deficient mdx Mice (2013) (3)
An X:autosome translocation stabilizes truncated dystrophin: implications for lack of truncated dystrophins in Duchenne muscular dystrophy. (1995) (3)
Workshop on inflammatory myopathy Bethesda, 5–6 April 2000 (2001) (2)
Prenatal diagnosis in a family affected with β-sarcoglycan muscular dystrophy (1999) (2)
P.103 DMD genotypes and loss of ambulation in the CINRG Duchenne natural history study (2016) (2)
AKT 1 polymorphisms are associated with risk for metabolic syndrome (2019) (2)
A new long-read RNA-seq analysis approach identifies and quantifies novel transcripts of very large genes (2020) (2)
Exome Sequencing Identifies DYNC1H1 Variant Associated with Vertebral Abnormality and SMA-LED (2015) (2)
Validation of Chemokine Biomarkers in Duchenne Muscular Dystrophy (2021) (2)
A feasible roadmap for unsupervised deconvolution of two-source mixed gene expressions (2013) (2)
Oxidative Stress Response Genes Upregulated During Unloading, Immobilization, and Spinal Cord Injury: 2505 (2008) (2)
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle (2018) (2)
Sodium Channelopathies: Dramatic Diseases Caused (1993) (2)
PCB Exposure In Vitro (PBMC): Differential Gene Expression, Pathway Analysis for Possible Mode(s) of Actions, and Disease Development in Comparison with PCB-Exposed Slovak Population (2009) (2)
Towards fully automated genotyping: use of an X linked recessive spastic paraplegia family to test alternative analysis methods (2004) (2)
Upregulated IL-1β in dysferlin-deficient muscle attenuates regeneration by blunting the response to pro-inflammatory macrophages (2015) (2)
Mechanically Ventilated Patients with Suspected Pneumonia (2014) (2)
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle (2018) (2)
Prenatal diagnosis in a family affected with beta-sarcoglycan muscular dystrophy. (1999) (2)
Asthmatic Bronchial Epithelium Is Intrinsically Inflammogenic, Mitotically Dyssynchronous, And Is Rescued By Glucocorticoids (2010) (2)
A mouse model of inherited choline kinase β-deficiency presents with specific cardiac abnormalities and a predisposition to arrhythmia (2022) (2)
Genetic aspects of myopathy. (1989) (2)
and is directly regulated by Hsp70 FOXO signaling is required for disuse muscle atrophy (2011) (1)
Towards fully automated genotyping: use of an X linked recessive spastic paraplegia family to test alternative analysis methods (1995) (1)
An Intronic Variant in DCHS2 is Associated with Bone Mineral Density in Children and Young Adults (2017) (1)
Gene Selection by Weighted Fisher criterion for Multiclass Prediction (2005) (1)
Nuclear envelope laminopathies: evidence for developmentally inappropriate chromatin-nuclear envelope interactions (2013) (1)
ASSOCIATION BETWEEN POLYMORPHIC VARIATION IN THE CARP GENE AND MUSCLE SIZE AND STRENGTH (2003) (1)
21-Hydroxylase Heterozygotism and Immune Regulation—Authors’ Responsed (1997) (1)
Hyperkalaemic periodic paralysis: Mother nature versus human nature (2008) (1)
Association Of Akt2 Genotypes And Exercise Muscle Damage: 651 (2008) (1)
INCREASED C-FOS EXPRESSION FOLLOWING A SINGLE BOUT OF ECCENTRIC VERSUS CONCENTRIC EXERCISE (2002) (1)
Optimizing multilayer perceptrons by discriminatory component analysis (2004) (1)
Sepsis Alters the Megakaryocyte-Platelet Transcriptional Axis Resulting in Platelet Lymphotoxicity. (2009) (1)
Sparse Decomposition of Gene Expression Data to Infer Transcriptional Modules Guided by Motif Information (2008) (1)
The Effects of Aerobic Training on Markers of Systemic Inflammation in Extremely Obese Minority Teens: 2502 (2011) (1)
AKT1 Polymorphisms Demonstrate Role in Regulating Gene Expression: Functional Link between Polymorphisms and Physiotypes (2006) (1)
Low-Volume/Moderate-Intensity Aerobic Training Improves Insulin Action In Obese Minority Adolescent Females: 1650 (2010) (1)
Linkage and mutation analysis of Thomsen and Becker myotonia families (1994) (1)
Genetic modifiers of upper limb function in Duchenne muscular dystrophy (2022) (1)
Metabolic remodeling agents show beneficial effects in the dystrophin- deficient mdx mouse model (2012) (1)
TCTEX1D1 is a genetic modifier of disease progression in Duchenne muscular dystrophy (2020) (1)
AKT1 Association with Body Composition: 568 (2007) (1)
The Myostatin A2379G Polymorphism and Muscle Strength Among African Americans: 1721 (2007) (1)
Association Among Age, Muscle Size And Strength In Young Adults: 677 4:00 PM ??? 4:15 PM (2005) (1)
Vision DMD: Vamorolone (VBP15) drug development program for Duchenne muscular dystrophy (2017) (1)
Genetic Modifiers of Cerebrovascular Large Vessel Stenosis in Sickle Cell Anemia. (2004) (1)
Eps homology domain endosomal transport proteins differentially localize to the neuromuscular junction (2012) (1)
Book Review Genetics and Neurology (Genetics in Medicine and Surgery Series.) Second edition. By Sarah Bundey, with a contribution by E.M. Brett. 459 pp., illustrated. New York, Churchill Livingstone, 1992. $125. 0-443-04523-2 (1993) (1)
Vitamin D Receptor Polymorphisms are Associated with Baseline Muscle Strength and Response to Strength Training (2017) (1)
Genome-wide identification of significant aberrations in cancer genome (2012) (1)
α SARCOGLYCAN DEFICIENCY, TWO NOVEL MUTATIONS (1997) (1)
Composite Gene Module Discovery using Non-negative Independent Component Analysis (2006) (1)
Identification of Early Disease Biomarkers in 45 Months PCB-Exposed Slovak Population (2009) (1)
Novel Genetic Variation in Muscle Genes Correlated with Muscle Strength, Size and Response to Resistance Training (FAMuSS) (2004) (1)
Resistance exercise improves function and reduces the expression of inflammation and fibrosis genes in skeletal muscle of autoimmune myositis patients. (2007) (1)
Expression Profiling as a Tool for Diagnosis and Pathway Discovery: Experimental Design and Technical Considerations (2004) (1)
Δ-9 , 11 modification of glucocorticoids dissociate NF-κ B inhibitory efficacy from GRE-associated side effects (2012) (1)
Asymmetric independence modeling identifies novel gene-environment interactions (2019) (1)
Systems Biology Through Time Series Data—A Strength of Muscle Remodeling (2010) (1)
Effects of non-disease genetic information on the self-concept of individuals in the FAMuSS study. (2002) (1)
Decreased Platelet Expression of MYL9 (Myosin Regulatory Light Chain Polypeptide) and Other Genes with Platelets Dysfunction and CBFA2 Mutation: Insights from Platelet Expression Profiling. (2004) (1)
P.267Modifiers of respiratory and cardiac function in the Italian Duchenne muscular dystrophy network and CINRG Duchenne natural history study (2019) (1)
G.P.2.04 Gene expression and muscle fiber function in a porcine AQM-ICU model (2009) (1)
Obesity-related Genetic Variants And Their Associations With Physical Activity: 322 Board #173 May 27, 11 (2015) (1)
CLINICAL TRIAL HIGHLIGHTS O.3a 2.5-years of vamorolone treatment in Duchenne muscular dystrophy: Results of an open label long-term extension (2021) (1)
Genome-Wide Association Studies in Muscle Physiology and Disease (2019) (1)
P1.56 Submaximal exercise effects on mdx mouse model (2011) (1)
Influence of Socioeconomic Status on Parental and Child Cardiovascular Disease Risk Factors: 3369 Board #130 May 30, 8 (2015) (1)
Effects of Chronic, Maximal Phosphorodiamidate Morpholino Oligomer (PMO) Dosing on Muscle Function and Dystrophin Restoration in a Mouse Model of Duchenne Muscular Dystrophy. (2021) (1)
P.337Dystrophin restoration by exon 53 skipping in patients with Duchenne muscular dystrophy after viltolarsen treatment: phase 2 study update (2019) (1)
NEW THERAPEUTIC APPROACHES AND THEIR READOUT O.15Humoral and cell mediated immune response to new dystrophin after morpholino-induced exon skipping therapy in dystrophin-deficient mdx mice (2018) (1)
Determination of presynaptic acetylcholine terminal densities and its clinical correlation in Retts syndrome (2003) (1)
A Single Nucleotide Polymorphism (SNP) in Titin (TTN) Decreases Muscle Soreness and Strength Deficits after Eccentric Exercise in Women (2010) (1)
Progression of a Muscular Dystrophy Due to a Genetic Defect in Membrane Synthesis is Driven by Large Changes in Neutral Lipid Metabolism (2021) (1)
NKG2A inhibits TH2 cell effector function in vitro (2007) (1)
P.345 Serum biomarker discovery for congenital muscular dystrophies (2016) (1)
Leptin and Leptin Receptor Genetic Variants Associate with Habitual Physical Activity and Body Composition Changes in Response to Resistance Training: 993 (2011) (1)
Identification of condition-specific regulatory modules through multi-level motif and mRNA expression analysis (2009) (1)
Facilitating orphan drug development: Proceedings of the TREAT-NMD International Conference, December 2015, Washington, DC, USA (2017) (1)
P.473 Do titin developmental isoforms contribute to the pathogenesis of congenital titinopathy? (2017) (1)
PDPR Gene Expression Correlates with Exercise-Training Insulin Sensitivity Changes. (2016) (1)
Short Read ( Next-gen ) Sequencing : A Tutorial with Cardiomyopathy Diagnostics as an Exemplar (2013) (1)
21: The Prevalence of Insulin Resistance in Sedentary, Obese, and Otherwise Healthy Minority Adolescents in the DC Metropolitan Area (2008) (1)
P.97 Multi-minicore myopathy without epidermolysis bullosa simplex: A new plectin phenotype (2016) (1)
G.P.285 TREAT-NMD (translational research in Europe, assessment and treatment for neuromuscular disorders) (2015) (1)
X-linked lethal infantile (XL)-SMA: new clinical information, variant phenotypes, and candidate disease gene studies. (2004) (1)
THE PATHOLOGICAL SPECTRUM OF MEROSIN DEFICIENCY: IMPLICATIONS FOR PATHOGENESIS (1996) (1)
Biceps Brachii Regional Growth In Response To 12-weeks Of Resistance Training: 681 5:00 PM ??? 5:15 PM (2005) (0)
Resistin Polymorphisms Alters The Muscle Strength Response To Resistance Training: 1255 Board #110 3:30 PM ??? 5:00 PM (2005) (0)
MODELS Sparing of the Dystrophin-De fi cient Cranial Sartorius Muscle Is Associated with Classical and Novel Hypertrophy Pathways in GRMD Dogs (2013) (0)
Aging influences the expression of early response genes following acute resistance exercise in trained skeletal muscle (2013) (0)
Genetic medicine and the muscular dystrophies: triumphs and tribulations (2002) (0)
IGF2 ApaI Polymorphism Influences Physical Activity Participation: 1575 (2008) (0)
A complete ascertainment haplotyping in a SNP-Intensive gene: Clear population-specific haplotypes in the Cardiac Ankyrin Repeat Protein (CARP) gene (2002) (0)
Sphingosine Phosphate Lyase Is Upregulated in Duchenne Muscular Dystrophy, and Its Inhibition Early in Life Attenuates Inflammation and Dystrophy in Mdx Mice (2022) (0)
Osteopontin in Duchenne Muscular Dystrophy (S15.002) (2012) (0)
Using oligonucleotide arrays (2005) (0)
strongly repressed by conditions that cause skeletal muscle atrophy Spermine oxidase maintains basal skeletal muscle gene expression and fiber size and is (2015) (0)
Sexual dimorphism and variations in mechanical loading influence humeral bone volume in the young adult skeleton (2009) (0)
584. Myoblast Fusion Mediates Morpholino Entry and Exon Skipping In Dystrophic Muscle (2016) (0)
AFMR Eastern Region Annual Meeting Abstracts (2008) (0)
ModVis: An information visualization tool for gene module discovery (2006) (0)
Table 5. [Testing Used to Establish LGMD Type]. (2012) (0)
Building a Coherent Data Pipeline in Microarray Data Analyses: Optimization of Signal/Noise Ratios Using an Interactive Visualization Tool and a Novel Noise Filtering Method (2003) (2005) (0)
Possession Of Slc30a8 TT Genotype Mitigates The Effects Of Eccentric Exercise In Men: 866 (2010) (0)
Edinburgh Research Explorer Large meta-analysis of genome-wide association studies identifies five loci for lean body mass (2018) (0)
Rett syndrome: New progress towards the molecular basis of an enigmatic disorder (1999) (0)
Polymorphisms of Candidate Genes in a Vascular Endothelial Cell Pathway and Lung Function. The MESA-Lung Study. (2009) (0)
Analysis of Mutation Pattern of Duchenne Muscular Dystrophy (DMD) in Sri Lanka A Cohort Study (2017) (0)
Beneficial Glucocorticoid Effects In Asthmatic Airway Epithelium Are Not Dependent On Receptor-Mediated Transcription (2011) (0)
NOS3 deficiency is associated with a shift toward pro-oxidant gene expression in murine myocardium (2002) (0)
in a porcine intensive care unit model Role of sepsis in the development of limb muscle weakness (2013) (0)
Table 3. [Molecular Genetics of Autosomal Dominant LGMD]. (2012) (0)
623. Dystrophin Exon 52-Deleted Pigs as a New Animal Model of Duchenne Muscular Dystrophy: Its Characterization and Potential as a Tool for Developing Exon Skipping Therapy (2016) (0)
Investigation Of SNPs In The TCFL72 And INSIG2 Genes With Fat And Metabolic Phenotypes: 1718 (2007) (0)
Serum Creatine Kinase Response To Initiation Of Resistance Training Predicts Hypertrophic Response In Men: 2257 (2009) (0)
Insight into genetic testing for non-disease traits: a qualitative assessment. (2003) (0)
Synchronizing Mitosis Reduces Intrinsic Inflammation In Asthmatic Airway Epithelium (2011) (0)
Cross phenotype normalization of microarray data. (2010) (0)
Non-random XCI and second trimester RSA family maps to xq28 (2002) (0)
Training Decreased Resistance Exercise-Induced Macrophage Recruitment And Increased Macrophage M2 Polarization In Skeletal Muscle: 2503 (2011) (0)
Differential expression of cathepsins and related endogenous cathepsin inhibitors after spinal cord injury in the mouse (2007) (0)
Intelligent DNA-Based Molecular Diagnostics Using Linked Genetic Markers (1994) (0)
AKT2 -G318A Genotype is Associated with Muscle Size in Men: 11:00AM–11:15AM (2006) (0)
The effect of vitamin E on gene expression in patients with age-related macular degeneration (AMD) (2003) (0)
Book Review The History of a Genetic Disease: Duchenne muscular dystrophy or Meryon's disease By Alan E.H. Emery and Marcia L.H. Emery. 248 pp., illustrated. London, Royal Society of Medicine Press, 1995. $35. 1-85315-249-3 (1997) (0)
Inferring Condition-Specific miRNA-Gene Modules from miRNA and mRNA Profiling Data (2008) (0)
IGF1R Pathway is Related to Enhanced Insulin Sensitivity Following Exercise Training (2014) (0)
Lack Of Normal Mitotic Synchrony In Regenerating Asthmatic Airway Epithelium Drives Basolateral Secretion Of TGF-²1 (2012) (0)
Differences in Functional and Genetic Characteristics of Circulating Late Outgrowth Endothelial Progenitor Cells (OEC) and Standard Endothelial Cell Lines (2006) (0)
Integrative Network Component Analysis for Regulatory Network Reconstruction (2008) (0)
Gene Expression Analysis of PCB Exposed Children: Understanding Toxicity and Disease Process (2011) (0)
The effect of genetic modifiers on phenotypic variation in cystic fibrosis-associated pulmonary disease (2002) (0)
Reply to Migeon and Haisley-Royster (1998) (0)
Muscle Size and Strengths and their Associations with Sports Participation among Young Adults: 508 Board #6 May 30 1 (2018) (0)
An Iterative Nonlinear Regression Method for Microarray Data Normalization (2007) (0)
The SORT1 risk allele is associated with exaggerated postprandial lipaemia in young adults (383.5) (2014) (0)
Gene Expression Changes Associated with Insulin Sensitivity Variation Following Exercise Training: 729 Board #125 May 27, 2 (2015) (0)
Rett Syndrome (1998) (0)
Genetic medicine and the muscular dystrophies: triumphs and tribulations. (2002) (0)
Association of MYLK C37885A Genotype with Skeletal Muscle Volume in Caucasian Females (2007) (0)
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle (2018) (0)
Vdr Variants Influence Physical Activity Participation: 1066 (2009) (0)
The Inhibition of Cancerous Stem Cells (2007) (0)
Non-hormonal steroidmodulatorer of NF-? B for the treatment of disease (2009) (0)
CONGENITAL ADRENAL HYPERPLASIA DUE TO 21-HYDROXYLASE (21-OHase) DEFICIENCY: PHENOTYPE/GENOTYPE CORRELATIONS IN NEWBORN SCREENING.† 553 (1996) (0)
P-226 Pharmacodynamic Serum Biomarker Discovery in Pediatric Inflammatory Bowel Diseases (2016) (0)
Free Communication/Poster ??? Circulation: Exercise Training, Blood Pressure Vascular Adaptations To 12-weeks Of Resistance Training (2005) (0)
BASIC FIBROBLAST GROWTH FACTOR AND MUSCULAR DYSTROPHY. AUTHORS' REPLY (1994) (0)
Biceps Insertion Distance Influences Elbow Flexor Isometric Force at 900 Joint Angle: 1342 Board #197 3:30 PM - 5:00 PM (2005) (0)
Muscle Strength And Size Correlations At Baseline And Following Unilateral Resistance Training (2020) (0)
hypertrophy activates divergent transcriptional programs in cardiac Deficiency of different nitric oxide synthase isoforms (2003) (0)
Allometric Scaling Models of Isometric Biceps Strength and the Effects of Resistance Training in Men: 1793 (2006) (0)
NEGATIVE ISOLATION OF TH2 CELLS FOR LUNG INJURY RESEARCH.: 27 (2004) (0)
Epigenetic networks and skeletal muscle plasticity to resistance and endurance exercise in type-II diabetic obesity (2013) (0)
isometric contractions, and lengthening contractions Muscle inflammatory cells after passive stretches, (2015) (0)
Polymorphisms From GWAS Studies Are Associated With BMI and Post-Exercise Fat Loss In College Students: 2924 (2010) (0)
Association of a Polymorphism in the Estrogen Receptor 1 Gene with Fasting Glucose Levels in Caucasians (2008) (0)
M.I.3 Genetic modifiers of muscle: Studies of college students and Duchenne muscular dystrophy (2015) (0)
Allometric Scaling of Isometric Biceps Strength in Adult Females is Unaffected by Resistance Training: 1790 (2006) (0)
Biochemical/molecular/clinical correlations in sarcoglycan complex disorders (1996) (0)
Probe and procedure for diagnosis of muscular dystrophy (1989) (0)
Variants in MCP1 and MCP1R are Associated with Baseline Muscle Size and Strength: 1551 (2008) (0)
Clinical utility of serum biomarkers in Duchenne muscular dystrophy (2016) (0)
High-resolution mass spectrometry-based non-targeted metabolomic discovery of disease and glucocorticoid biomarkers in an animal model of muscular dystrophy (2018) (0)
Resistance Exercise Produces A Metabolic Gene Expression Signature Similar To Endurance Exercise: 1966 (2009) (0)
Identification of Allergen-Susceptibility Genes Using Recombinant Inbred Mouse Model of Allergic Asthma (2007) (0)
Homeostasis Model Assessment Of Insulin Resistance Is Inversely Associated With The Adaptive Strength Response To Resistance Exercise In Adults: 666 (2011) (0)
Single Nucleotide Polymorphisms in CLDN14 and SMOC1 Affecting Bone Mineral Density Influence Other Musculoskeletal Traits (2016) (0)
Association of PGC-lα Gly482Ser Variant with Metabolic Syndrome Risk Factors in Caucasian Males: 2497 (2007) (0)
G.P.10.07 Role of inflammasome in the pathogenesis of dysferlin deficiency (2008) (0)
Reply from the Authors (1996) (0)
Gene Expression Profiling on Skeletal Muscle after Exercise Training (2008) (0)
Molecular Diagnosis and Genetic Counseling of the Manifesting Carrier of Duchenne Muscular Dystrophy (2001) (0)
Association Of Atrogin-1 Genotypes With Baseline Muscle Phenotypes: 2965 (2009) (0)
Automated genotyping of dinucleotide repeat markers (1994) (0)
Table 2. [Findings in the α-Dystroglycanopathies]. (2012) (0)
035. CANDIDATE BIOMARKERS IN ANCA-ASSOCIATED VASCULITIS IDENTIFIED USING A PROTEOMIC APPROACH (2019) (0)
PPARα L162V Shows Strong Sex-Specific Effects on Subcutaneous Arm Fat Volume: 2088 (2006) (0)
Author Correction: Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle (2018) (0)
Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice (2010) (0)
The Angiotensin Converting Enzyme Insertion/Deletion Polymorphism Associates with Habitual Physical Activity among European-American Adults: 2625 Board #148 June 3, 9: 30 AM - 11: 00 AM. (2016) (0)
Eastern Regional Meeting at a Glance (2014) (0)
IGF2 G3579C Polymorphism and Adiposity Associate with Adherence to a Resistance Training Program: 785 (2006) (0)
ET-64PRE-CLINICAL ASSESSMENT OF DISSOCIATIVE STEROIDS AS DEXAMETHASONE SUBSTITUTE FOR TREATMENT IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG) (2014) (0)
Eastern Regional Meeting Abstracts (2010) (0)
The 1p13.3 LDL-Associated Locus Shows Large Effect Sizes in Young Populations: 2920 (2010) (0)
IL-15 and IL-15R-alpha SNP Associations with Markers of the Metabolic Syndrome and Adaptations to Resistance Training (2007) (0)
Expression profiling in human muscle disease: identification of early transcription changes consequent to dystrophin deficiency, and design of a human muscle tissue oligonucleotide array chip (1999) (0)
Novel Approaches to Therapeutics of the Muscular Dystrophies (2000) (0)
Skeletal Response To 12-weeks Of Upper-arm Resistance Training: 2340 10:45 AM ??? 11:00 AM (2005) (0)
CHILDREN ’ S LATENT TRAIT CORTISOL – (2016) (0)
Molecular Aspects of Muscle Damage and Denervation with Public Access Tools (2005) (0)
Interaction Of Body Mass Index And Adiposity-related Gene Polymorphisms Influences Risk For Metabolic Syndrome: 2956 (2009) (0)
inflammation, and repair influence post-exercise indexes of muscle damage, Point:Counterpoint: Estrogen and sex do/do not (2015) (0)
African-American esophageal squamous cell carcinoma expression profile reveals dysregulation of stress response and detox networks (2017) (0)
Bayesian Network Analysis Suggests Ranking Of Major Clinical, Behavioral And Environmental Variables Influencing Asthma Outcomes (2012) (0)
MOESM1 of Clinical utility of serum biomarkers in Duchenne muscular dystrophy (2016) (0)
CHANGES IN MUSCLE SIZE & STRENGTH ARE SIMILAR IN LEAN AND OBESE WOMEN AFTER RESISTANCE TRAININ (2003) (0)
Vitamin D Receptor Genetic Variants And The Muscle Size And Strength Response To Resistance Training: 2957 (2009) (0)
A Preliminary Investigation Of Gene Expression Of C2C12 Myotubes Following In Vitro Simvastatin Application: 1266 Board #121 2:00 PM - 3:30 PM (2005) (0)
Association of Atrogin-1 genotypes with Metabolic Syndrome Risk Factors in Caucasian Females (2007) (0)
C:\Documents and Settings\senthil.d\Desktop\Bioinfo-26(11)issue\btq144.dvi (2010) (0)
Characterization of the dystrophin-associated protein complex by mass spectrometry. (2022) (0)
Table 1. [Congenital Muscular Dystrophies by Protein Defect and Gene]. (2012) (0)
Physical Activity and Physical Fitness as Determinants of Cardiometabolic Risk Factors_a Comparison between African Americans and Caucasian College Students: 654 Board #69 May 28, 3 (2014) (0)
Supporting Information - emmm201302621-sm-0002-SuppFig-S1 (2015) (0)
Variants in Ghrelin are Associated with Metabolic Syndrome Components and the Response to Strength Training: 992 (2011) (0)
Corrigendum: β-sarcoglycan (A3b) mutations cause autosomal recessive muscular dystrophy with loss of the sarcoglycan complex (1996) (0)
Microarray Analysis of Peripheral Blood Monocytes in Sickle Cell Anemia Patients with Cerebrovascular Stenosis. (2004) (0)
DISCOVERY OF SNPS IN GENES INVOLVED IN MUSCLE FUNCTION: COMPARISION OF SEQUENCING TO SNP DATABASES (2003) (0)
Indian Agarwal megalenceplialic leukodystrophy with cysts is caused by a common MLC1 mutation [2] (multiple letters) (2004) (0)
Exome Sequencing Identifies DYNC1H1 Variant Associated With Vertebral Abnormality and Spinal Muscular Atrophy With Lower (2015) (0)
Persistent Organic Pollutants and Their Effect on Gene Expression in Exposed Children (2011) (0)
Downstream of an RNA regulatory protein causing a common human disease: Expression-profiling human SMN-deficient muscle (2002) (0)
immune activation: a microarray analysis Resistance exercise training influences skeletal muscle (2012) (0)
Table 3. [Serum CK Concentration and Muscle...]. (2012) (0)
muscle: insights from animal models Functional characteristics of dystrophic skeletal (2015) (0)
Transcriptional Deficits In Oxidative Phosphorylation In Statin-induced Myopathy Patients Following Eccentric Exercise (2009) (0)
Apolipoprotein E Genotype And The Muscle Size And Strength Response To Resistance Training: 325 Board #176 May 27, 11 (2015) (0)
T cells expressing the gamma delta T cell receptor are prominent in mdx muscle (2002) (0)
AFMR EASTERN REGION ANNUAL MEETING PROGRAM SCHEDULE (2008) (0)
A Network-based Analysis Of Lung From A Novel Mouse Model Of Experimental Asthma (2007) (0)
DIA/NORD 2013 US Conference on Rare Diseases and Orphan Products: Poster Abstracts (2013) (0)
Sexual dimorphism in determinants of bone: MRI and strength study in 438 young adults. (2006) (0)
Knowledge of non-disease genetic traits and the effect on self-concept. (2003) (0)
An IGF1 Promoter Polymorphism is Associated with Muscle Function in the Health ABC and FMS cohorts: 1320 (2008) (0)
Elusive sources of variability of dystrophin rescue by exon skipping (2015) (0)
Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice (2010) (0)
neuromuscular junction microdissection: three novel components of the Intracellular expression profiling by laser capture (2015) (0)
Hyperandrogenism and CYP21 Manifesting Heterozygotes † 427 (1997) (0)
cardiomyopathic Syrian hamster Increased compliance in diaphragm muscle of the (2015) (0)
contraction-induced skeletal muscle injury in mice contributes to adaptations that reduce Neutrophil accumulation following passive stretches (2015) (0)
Assessment of the myocardial transcriptome in heart failure using redundant cross-species oligonucleotide arrays (2002) (0)
CHAPTER 103 – The Genomic Basis of Neuromuscular Disorders (2009) (0)
Learning a highly resolved tree of phenotypes using genomic data clustering (2009) (0)
Molecular Diagnosis and Genetic Testing (2014) (0)
Correction: Functional and Molecular Effects of Arginine Butyrate and Prednisone on Muscle and Heart in the Dystrophin Deficient mdx mice (2010) (0)
Keynote - Heading Towards the 'Physiome' of Muscle in Health and Disease: Technologies and Applications: 256 (2008) (0)
Table 1. [Molecular Genetics of Autosomal Recessive Limb-Girdle Muscular Dystrophy (LGMD)]. (2012) (0)
DNA Methylation is Altered in Human Skeletal Muscle in Response to Exercise Training (2012) (0)
Dystrophin (1992) (0)
Genetic Variants in MCP1 and MCP1R are Associated with Markers of Muscle Damage: 1321 (2008) (0)
Table 2. [Autosomal Recessive LGMD: Clinical Findings]. (2012) (0)
A novel estrogen receptor 1-sphingomyelin phosphodiesterase acid like 3B pathway mediates rituximab response in myositis patients. (2022) (0)
Membrane regulation in dysferlin deficiency: Evidence for disrupted membrane signaling and altered remodeling through expression profiling (2002) (0)
Eastern Regional Meeting at a Glance (2015) (0)
Chapter 91 – Dystrophinopathies (2015) (0)
Metabolic Fatty Liver Disease (2009) (0)
VBP15, a Novel Anti-Inflammatory, is Effective at Reducing the Severity of Murine Experimental Autoimmune Encephalomyelitis (2014) (0)
interventions in porcine skeletal muscle protein synthesis in response to critical illness Impaired autophagy, chaperone expression, and (2014) (0)
Steroid Hormones in Asthma (2012) (0)
Elucidating the Molecular Role of AKT1 SNPs in Determining Human Physiotypes: 2496 (2007) (0)
Associations Between Mtor Genotypes And Strength Loss After Eccentric Exercise: 1064 (2009) (0)
Asymptomatic African Americans with high‐risk APOL1 genotypes have reduced urinary angiogenesis‐promoting cytokines (2013) (0)
BMP2 and IL-10 Genotype Associations with Body Composition: 1327 (2008) (0)
Predicting age at loss of ambulation in Duchenne muscular dystrophy with deep phenotypic measures (2014) (0)
American Federation for Medical Research Eastern Regional Meeting April 26-27, 2011 (2011) (0)
The CNTF G1357A Polymorphism and Gender Alter the Muscle Strength Response to Resistance Training: 1783 (2007) (0)
Validation of a Genetic Risk Score Based on Single Nucleotide Polymorphisms Implicated in Adult Bone Fragility and Associated with Pediatric Bone Density (2017) (0)
Reliability Analysis of Transcriptional Regulatory Networks (2008) (0)
Pregnancy associated myotonia (1996) (0)
Table 4. [Autosomal Dominant LGMD: Clinical Findings]. (2012) (0)
functiondoes not impair mouse diaphragm isotonic Myofibrillar or mitochondrial creatine kinase deficiency (2015) (0)
ACTN3 Genotype Effects on Skeletal Muscle Gene Expression: 867 (2010) (0)
186A ABSTRACTS-Cardiac Function and Heart Failure (2002) (0)
Myotonic dystrophy muscle shows decreased insulin receptor RNA: relationship to increased insulin resistance (1996) (0)
Science Signaling Podcast: 7 August 2012 (2012) (0)
P1.57 Neuropsychological profiles in children with Duchenne muscular dystrophy compared to dyslexic population (2011) (0)
Biomarkers for Muscle Disease Gene Therapy (2019) (0)
The Role of Microglia and NADPH Oxidase in Traumatic Spinal Cord Injury (2006) (0)
Myoblasts and macrophages are required for therapeutic morpholino antisense oligonucleotide delivery to dystrophic muscle (2017) (0)
An analysis of DNA methylation in human adipose tissue reveals differential modification of obesity genes before and after gastric bypass and weight loss (2015) (0)
Single Nucleotide Polymorphisms and Inflammation and Oxidative Stress Biomarkers in Community Adults: 2200 (2011) (0)
Eastern Regional Meeting Abstracts (2011) (0)
Applying A Novel Population Assignment Method To A Cohort Of Children With Asthma: Implications For Pediatric Research (2010) (0)
TIMP-1 Nucleates a Critical Bronchial Epithelial Response Network to Tobacco Smoke in Asthma (2012) (0)
Fetal Muscle Biopsy (2001) (0)
Endothelial Nitric Oxide Synthase ( NOS 3 ) + 894 G > T Associates with Physical Activity andMuscle Performance among Young Adults (2014) (0)
Changes In Aquaporin-4 Gene Expression In Skeletal Muscle Is Associated With Statin-induced Myalgia: 542 (2007) (0)
Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies (2012) (0)
influences damage mediated by leukotrienes Timing of hyperoxic exposure during alveolarization (2007) (0)
The mouse rumpshaker mutation of the proteolipid protein in human X-linked recessive spastic paraplegia (1994) (0)
Use of Primary Retinal Pigment Epithelia (RPE) Cultures Derived From Healthy and AMD Affected Post–Mortem Donor Eyes for the Evaluation of Injury–Induced Differences in Gene Expression Patterns (2005) (0)
Novel mutation identification and copy number variant detection via exome sequencing in congenital muscular dystrophy (2020) (0)
Prevalence of vitamin D insufficiency in African-American children with forearm fractures (2007) (0)
ACTN3 genotype predicts metabolic, anthropometric and cardiovascular phenotypes in a young, healthy population (711.8) (2014) (0)
Influence of β1 Adrenergic Receptor Genotype on Longitudinal Measures of Left Ventricular Ejection Fraction and Responsiveness to ß-Blocker Therapy in Patients With Duchenne Muscular Dystrophy (2022) (0)
Gene Expression Profiling of the Repeated Bout Effect (2004) (0)
P.10.21 Next-generation sequencing meets genetic diagnostics: Development of a comprehensive workflow for neuromuscular disorders (2013) (0)
FP.27 Results of a double-blind cross-over trial of vamorolone in DMD: A safer alternative to corticosteroids (2022) (0)
G.P.254 VISION – DMD: Drug development of VBP15, an experimental steroid-like drug for DMD (2015) (0)
DMD - TREATMENT EP.140 Long-term efficacy and safety of viltolarsen in the treatment of Duchenne muscular dystrophy (2021) (0)
DMD CLINICAL THERAPIES I P.114Vamorolone as a replacement for corticosteroids in Duchenne muscular dystrophy: phase 2a results in 48 DMD boys (2018) (0)
Efficacy and Safety of Viltolarsen in Boys With Duchenne Muscular Dystrophy: Results From the Phase 2, Open-Label, 4-Year Extension Study. (2023) (0)
P.133 Daily regimens of prednisone, deflazacort and vamorolone improve motor function similarly in patients with Duchenne muscular dystrophy (2022) (0)
D.P.1 Next-generation sequencing approach for muscular dystrophy diagnosis: Advantages and pitfalls of new diagnostic technology (2012) (0)
P.336Vision DMD: a phase IIb randomized, double-blind, parallel group, placebo- and active-controlled study to assess the efficacy and safety of vamorolone in boys with Duchenne muscular dystrophy (2019) (0)
Duchenne Muscular Dystrophy in monozygotic twins: first follow up study worldwide (2016) (0)
P.462 Exploring physical activity levels and sleep efficiency relationships among boys with Duchenne muscular dystrophy (DMD) (2017) (0)
DMD – ANIMAL MODELS & PRECLINICAL TREATMENT P.217 Enhancing the rigor and reproducibility of preclinical efficacy drug trials for DMD using reduced number of wild type and mdx control mice (2020) (0)
P.71 Vamorolone has less impact than daily prednisone or deflazacort on height and body mass index in patients with Duchenne muscular dystrophy (DMD) (2022) (0)
P.344 A novel COL12A1 variant expands the clinical picture for a collagen XII-related myopathy (2016) (0)
P4.12 AMPK and PPAR-delta agonists show beneficial effects in the mdx mouse model (2011) (0)
D37 Vision DMD: A drug development program for vamorolone in Duchenne muscular dystrophy (2017) (0)
OD01 Clinical characterisation of a large international congenital titinopathy cohort (2017) (0)
Influence of β2 adrenergic receptor genotype on longitudinal measures of forced vital capacity in patients with Duchenne muscular dystrophy (2022) (0)
DMD – BIOMARKERS & OUTCOME MEASURES P.118 Elevation of fast, but not slow TnI in plasma from Duchenne and Becker muscular dystrophy patients suggests differential fiber response to disease (2020) (0)
P.226 Vision DMD: Vamorolone drug development program for Duchenne muscular dystrophy (2016) (0)
DMD - TREATMENT EP.147 2.5-years of vamorolone treatment in Duchenne muscular dystrophy: Results of an open label long-term extension (2021) (0)
P.309 Success of preclinical drug trials using reliable and reproducible endpoints in mouse models of neuromuscular diseases (2017) (0)
FP.03 The spine fracture burden in boys with DMD treated with the novel dissociative steroid vamorolone versus deflazacort and prednisone (2022) (0)
DUCHENNE MUSCULAR DYSTROPHY - PHYSIOTHERAPY P.302Genetic association study of articular range of motion in the CINRG Duchenne natural history study (2018) (0)
P.59 Long-term benefits of glucocorticoids in Duchenne muscular dystrophy: is it worth it? (2017) (0)
DMD CLINICAL THERAPIES II P.128A phase II, dose finding study to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics of NS-065/NCNP-01 in boys with Duchenne muscular dystrophy (2018) (0)
Modeling Early Heterogeneous Rates of Progression in Boys with Duchenne Muscular Dystrophy. (2023) (0)
P.404 Drug development of vamorolone for Duchenne muscular dystrophy (2017) (0)
Gene therapy for selected neuromuscular and trinucleotide repeat disorders – An insight to subsume South Asia for multicenter clinical trials (2023) (0)
REGISTRIES AND CARE OF NEUROMUSCULAR DISORDERS P.297Treatment responsive outcome measures in mouse models of neuromuscular disease (2018) (0)
T.O.2 Systemic delivery of morpholino oligonucleotides to skip mutations in the dystrophin gene of the mouse and dog (2007) (0)
S.O.2 Analysis of a large international cohort confirms that recessively inherited loss-of-function TTN mutations cause prenatal or infant-onset muscle disease, often complicated by early cardiorespiratory involvement (2016) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Eric Hoffman?

Eric Hoffman is affiliated with the following schools:

Eric Hoffman's Academic­Influence.com Rankings

Why Is Eric Hoffman Influential?

Eric Hoffman's Published Works

Published Works

What Schools Are Affiliated With Eric Hoffman?

Eric Hoffman's AcademicInfluence.com Rankings